Sales of antidepressants, suicides and hospital admissions for depression in Veneto Region, Italy, from 2000 to 2005: An ecological study

Annals of General Psychiatry

Volumn 10, Issue , 2011, Pages

  Guaiana, Giuseppe ^a   Andretta, Margherita ^b   Griez, Eric ^c   Biancosino, Bruno ^d   Grassi, Luigi ^e  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b Servizio Farmaceutico ULSS 20   (Italy)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d Azienda USL Ferrara   (Italy)

^e UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; DEPRESSION; FEMALE; HOSPITAL PHARMACY; HOSPITALIZATION; HUMAN; ITALY; MALE; SUICIDE;

EID: 80053361619     PISSN: None     EISSN: 1744859X     Source Type: Journal    
DOI: 10.1186/1744-859X-10-24     Document Type: Article

References (33)

1. Isacsson G, Rich C. Antidepressant medication prevents suicide: a review of ecological studies. Eur Psychiatr Rev 2008, 1:24-26.
2. Guaiana G, Andretta M, Corbari L, Mirandola M, Sorio A, D'Avanzo B, Barbui C. Antidepressant drug consumption and public health indicators in Italy 1955 to 2000. J Clin Psychiatry 2005, 66:750-755. 10.4088/JCP.v66n0612, 15960569.
3. Rich CL, Isacsson G. Suicide and antidepressants in south Alabama: evidence for improved treatment of depression. J Affect Disord 1997, 45:135-142. 10.1016/S0165-0327(97)00067-0, 9298426.
4. Healy D, Aldred G. Antidepressant drug use and the risk of suicide. Int Rev Psychiatry 2005, 17:163-172. 10.1080/09540260500071624, 16194787.
5. Isacsson G, Rich C, Jureidin J, Raven M. The increased use of antidepressants has contributed to the worldwide reduction in suicide rates. Br J Psychiatry 2010, 196:429-433. 10.1192/bjp.bp.109.076166, 20513850.
6. Isacsson G, Bergman U, Rich C. Antidepressant depression and suicide: an analysis of the San Diego study. J Affect Disord 1994, 32:277-286. 10.1016/0165-0327(94)90092-2, 7897092.
7. Barbui C, Esposito E, Cipriani A. Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies. CMAJ 2009, 180:291-297. 10.1503/cmaj.081514, 2630355, 19188627.
8. Vyssoki B, Willeit M, Blüml V, Höfer P, Erfurth A, Psota G, Lesch OM, Kapusta ND. Inpatient treatment of major depression in Austria between 1989 and 2009: Impact of downsizing of psychiatric hospitals on admissions, suicide rates and outpatient psychiatric services. J Affect Disord 2011, 133:93-96. 10.1016/j.jad.2011.03.031, 21497914.
9. Roy AC. Depressed patients who suicide at their first attempt have had few admissions. Depress Anxiety 1999, 9:75-77. 10.1002/(SICI)1520-6394(1999)9:2<75::AID-DA5>3.0.CO;2-D, 10207662.
10. Goldberg JF, Harrow M, Whiteside JE. Risk for bipolar illness in patients initially hospitalized for unipolar depression. Am J Psychiatry 2001, 158:1265-1270. 10.1176/appi.ajp.158.8.1265, 11481161.
11. Pope GC, Ellis RP, Ash AS, Liu CF, Ayanian JZ, Bates DW, Burstin H, Iezzoni LI, Ingber MJ. Principal Inpatient Diagnostic Cost Group Model for Medicare Risk Adjustment. Health Care Financ Rev 2000, 3:93-118.
12. Cheng ATA. Mental illness and suicide. Arch Gen Psychiatry 1995, 52:594-603.
13. Hardy P. Severe depression: morbidity-mortality and suicide. Encephale 2009, 35(Suppl 7):S269-S271.
14. Walsh D. Admissions for depression have not increased among men in the Republic of Ireland. BMJ 1998, 317:1158. 1114130, 9784473.
15. Shajahan PM, Cavanagh JT. Admission for depression among men in Scotland 1980-95: retrospective study. BMJ 1998, 316:1496-1497. 28549, 9582135.
16. ISTAT Annuario Statistico Italiano 2005, Rome, Italy: ISTAT, ISTAT.
17. Milan G. I suicidi nel Veneto. Boll Inf Sist Epidem Reg Veneto 2008, 3:5-8.
18. Italian Ministery of Health SDO Italian Ministery of Health., http://www.salute.gov.it/ricoveriOspedalieri/ric_informazioni/default.jsp
19. Italian Ministery of Health Rapporto Annuale sull'attività di ricovero ospedaliero 2005, Rome, Italy: Ministero della Salute, Italian Ministery of Health.
20. WHO Collaborating Centre for Drug Statistic Methodology Guidelines for ATC Classification and DDD Assignment 2003, Oslo, Norway: WHO Collaborating Centre for Drug Statistic Methodology, WHO Collaborating Centre for Drug Statistic Methodology.
21. Preti A, Miotto P. Increase in first admissions for schizophrenia and other major psychoses in Italy. Psychiatry Res 2000, 94:139-52. 10.1016/S0165-1781(00)00136-0, 10808039.
22. Barbui C, Broglio E, Laia AC, D'Agostino S, Enrico F, Ferraro L, Fiorio E, Miletti F, Pietraru C, Poggio L, Tognoni G. Cross-sectional database analysis of antidepressant prescribing in Italy. J Clin Psychopharmacol 2003, 23:31-34. 10.1097/00004714-200302000-00006, 12544373.
23. Trifirò G, Barbui C, Spina E, Moretti S, Tari M, Alacqua M, Caputi AP, Arcoraci V. UVEC group Antidepressant drugs: prevalence incidence and indication of use in general practice of Southern Italy during the years 2003-2004. Pharmacoepidemiol Drug Saf 2007, 16:552-559. 10.1002/pds.1303, 16917790, UVEC group.
24. Castelpietra G, Morsanutto A, Pascolo-Fabrici E, Isacsson G. Antidepressant use and suicide prevention: a prescription database study in the region Friuli-Venezia Giulia Italy. Acta Psychiatr Scand 2008, 118:382-388. 10.1111/j.1600-0447.2008.01240.x, 18754835.
25. Kupfer DJ, Frank E, Perel JM. The advantage of early treatment intervention in recurrent depression. Arch Gen Psychiatry 1989, 46:771-775.
26. Munoz-Arroyo R, Sutton M. Exploring potential explanations for the increase in antidepressant prescribing in Scotland using secondary analyses of routine data. Br J Gen Pract 2006, 56:423-428. 1839016, 16762123.
27. Vichi M, Masocco M, Pompili M, Lester D, Tatarelli R, Vanacore N. Suicide mortality in Italy 1980-2002. Psychiatry Res 2010, 175:89-97. 10.1016/j.psychres.2008.12.008, 19945752.
28. Khan A, Khan S, Kolts R, Brown WA. Suicide rates in clinical trials of SSRIs other antidepressants and placebo: analysis of FDA reports. Am J Psychiatry 2003, 160:790-792. 10.1176/appi.ajp.160.4.790, 12668373.
29. Ciuna A, Andretta M, Corbari L, Levi D, Mirandola M, Sorio A, Barbui C. Are we going to increase the use of antidepressants up to that of benzodiazepines?. Eur J Clin Pharmacol 2004, 60:629-634. 10.1007/s00228-004-0810-8, 15448956.
30. Brown C, Schulberg HC, Madonia MJ, Shear MK, Houck PR. Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders. Am J Psychiatry 1996, 153:1293-1300.
31. Hor K, Taylor M. Suicide and schizophrenia: a systematic review of rates and risk factors. J Psychopharmacol 2010, 24(Suppl):81-90. 10.1177/1359786810385490, 2951591, 20923923.
32. McIntyre RS, Muzina DJ, Kemp DE, Blank D, Woldeyohannes HO, Lofchy J, Soczynska JK, Banik S, Konarski JZ. Bipolar disorder and suicide: research synthesis and clinical translation. Curr Psychiatry Rep 2008, 10:66-72. 10.1007/s11920-008-0012-7, 18269897.
33. Vijayakumar L, Kumar MS, Vijayakumar V. Substance use and suicide. Curr Opin Psychiatry 2011, 24:197-202. 10.1097/YCO.0b013e3283459242, 21430536.